Fewer UC patients taking infliximab need surgery, study says

05/6/2013 | Healio

Treating severe ulcerative colitis with infliximab may reduce the likelihood patients will need a colon resection, researchers reported at a surgical conference. About 20% of UC patients generally need surgery, but researchers said the number was significantly reduced among those taking infliximab. Some 4.1% to 11.1% of treated patients underwent surgery, compared with 46.6% to 55.7% of untreated patients.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ